{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:23:25Z","timestamp":1787505805302,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome is a prevalent gynecological condition affecting primarily women of childbearing age. It is characterized by elevated androgen levels, ovulatory dysfunction, and morphological abnormalities. Despite extensive research from various perspectives, the etiology and pathogenesis of PCOS remain unclear. While controversial, many believe that individuals with PCOS exhibit a chronic low-grade inflammatory state. Cytokines play diverse roles in the initiation and progression of inflammation, contributing to this inflammatory milieu. Therefore, the aim of this study was to utilize publicly available genome-wide association study data to explore the potential causal relationship between cytokines and PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To accurately investigate the causal relationship between cytokines and PCOS, we initially defined cytokines using the GeneCrad and then identified cytokines in two independent large-scale plasma proteins. Subsequently, we employed a two-sample Mendelian randomization analysis framework. A series of quality control procedures were implemented to select eligible instrumental variables closely associated with the exposure. MR analysis was conducted using genome-wide association studies of PCOS in two independent European ancestry groups. Cochran, s Q test, MR-Egger and intercept test were employed to assess heterogeneity and pleiotropy in PCOS. Co-localization analysis, summary-data-based Mendelian randomization analysis, and HEIDI testing were utilized to further corroborate the relationship between positive findings and PCOS. Finally, systematical Mendelian randomization analysis between healthy lifestyle factors and PCOS-related proteins was conducted to identify which proteins could act as interventional targets by lifestyle changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In our investigation, we performed Mendelian randomization analysis on 33 cytokines in relation to PCOS using data from the deCODE and the Fenland. Our findings revealed that the plasma level of IL6R emerges as a notable protective factor against PCOS, exhibiting a substantial effect size. Moreover, we identified CCL22 as a significant risk factor for PCOS, a finding that was similarly validated and supported by independent cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our Mendelian randomization analysis, leveraging genome-wide association study data from a sizable population cohort, unequivocally delineated a causal relationship between IL6R and PCOS. These results underscore the involvement of cytokines in the pathogenesis of PCOS and highlight their potential as promising therapeutic targets for addressing this intricate disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-025-01647-w","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:58:37Z","timestamp":1743739117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plasma cytokine levels and PCOS risk: Mendelian randomization analysis reveals IL6R as a preventive factor"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiaopei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongrui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"7","key":"1647_CR1","first-page":"694","volume":"41","author":"A Szilagyi","year":"2003","unstructured":"Szilagyi A, Szabo I. Endocrine characteristics of polycystic ovary syndrome (PCOS). Indian J Exp Biol. 2003;41(7):694\u2013700.","journal-title":"Indian J Exp Biol"},{"issue":"6","key":"1647_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687\u2013708.","journal-title":"Hum Reprod Update"},{"key":"1647_CR3","doi-asserted-by":"publisher","first-page":"9240569","DOI":"10.1155\/2022\/9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with Polycystic Ovarian Syndrome (PCOS): a review of literature. J Healthc Eng. 2022;2022:9240569.","journal-title":"J Healthc Eng"},{"issue":"1","key":"1647_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","unstructured":"Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"5","key":"1647_CR5","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","volume":"87","author":"CG Solomon","year":"2002","unstructured":"Solomon CG, Hu FB, Dunaif A, Rich-Edwards JE, Stampfer MJ, Willett WC, Speizer FE, Manson JE. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab. 2002;87(5):2013\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1647_CR6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","volume":"95","author":"RA Wild","year":"2011","unstructured":"Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95(3):1073-1079 e1071-1011.","journal-title":"Fertil Steril"},{"issue":"1","key":"1647_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mce.2010.08.002","volume":"335","author":"A Repaci","year":"2011","unstructured":"Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2011;335(1):30\u201341.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"1647_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.metabol.2009.02.022","volume":"58","author":"F Gonzalez","year":"2009","unstructured":"Gonzalez F, Rote NS, Minium J, Kirwan JP. Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism. 2009;58(7):954\u201362.","journal-title":"Metabolism"},{"issue":"12","key":"1647_CR9","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1093\/humrep\/dei258","volume":"20","author":"M Yilmaz","year":"2005","unstructured":"Yilmaz M, Bukan N, Ayvaz G, Karakoc A, Toruner F, Cakir N, Arslan M. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Hum Reprod. 2005;20(12):3333\u201340.","journal-title":"Hum Reprod"},{"issue":"11","key":"1647_CR10","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439\u201373.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"1647_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270\u201384.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1647_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1210\/er.2004-0004","volume":"26","author":"HF Escobar-Morreale","year":"2005","unstructured":"Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev. 2005;26(2):251\u201382.","journal-title":"Endocr Rev"},{"issue":"11","key":"1647_CR13","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s001250051451","volume":"42","author":"JM Fernandez-Real","year":"1999","unstructured":"Fernandez-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype\/phenotype to thriftiness. Diabetologia. 1999;42(11):1367\u201374.","journal-title":"Diabetologia"},{"issue":"4","key":"1647_CR14","first-page":"353","volume":"14","author":"JV Neel","year":"1962","unstructured":"Neel JV. Diabetes mellitus: a \u201cthrifty\u201d genotype rendered detrimental by \u201cprogress\u201d? Am J Hum Genet. 1962;14(4):353\u201362.","journal-title":"Am J Hum Genet"},{"issue":"11","key":"1647_CR15","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1210\/jc.2016-2586","volume":"101","author":"DA Dumesic","year":"2016","unstructured":"Dumesic DA, Akopians AL, Madrigal VK, Ramirez E, Margolis DJ, Sarma MK, Thomas AM, Grogan TR, Haykal R, Schooler TA, et al. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab. 2016;101(11):4178\u201388.","journal-title":"J Clin Endocrinol Metab"},{"key":"1647_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35: 100937.","journal-title":"Mol Metab"},{"issue":"12","key":"1647_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3109\/09513590.2012.683082","volume":"28","author":"E Deligeoroglou","year":"2012","unstructured":"Deligeoroglou E, Vrachnis N, Athanasopoulos N, Iliodromiti Z, Sifakis S, Iliodromiti S, Siristatidis C, Creatsas G. Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol Endocrinol. 2012;28(12):974\u20138.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"1647_CR18","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.fertnstert.2008.10.070","volume":"93","author":"C Kaya","year":"2010","unstructured":"Kaya C, Pabuccu R, Berker B, Satiroglu H. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors. Fertil Steril. 2010;93(4):1200\u20137.","journal-title":"Fertil Steril"},{"issue":"2","key":"1647_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1210\/jc.2003-031365","volume":"89","author":"HF Escobar-Morreale","year":"2004","unstructured":"Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Millan JL. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab. 2004;89(2):806\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1647_CR20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1365-2265.2009.03523.x","volume":"71","author":"D Glintborg","year":"2009","unstructured":"Glintborg D, Andersen M, Richelsen B, Bruun JM. Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment. Clin Endocrinol (Oxf). 2009;71(5):652\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1647_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejogrb.2011.03.015","volume":"157","author":"W Hu","year":"2011","unstructured":"Hu W, Qiao J, Yang Y, Wang L, Li R. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):53\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"1647_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.yjmcc.2008.06.003","volume":"45","author":"SC de Jager","year":"2008","unstructured":"de Jager SC, Kraaijeveld AO, Grauss RW, de Jager W, Liem SS, van der Hoeven BL, Prakken BJ, Putter H, van Berkel TJ, Atsma DE, et al. CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events. J Mol Cell Cardiol. 2008;45(3):446\u201352.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"1647_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fertnstert.2011.11.023","volume":"97","author":"AJ Duleba","year":"2012","unstructured":"Duleba AJ, Dokras A. Is PCOS an inflammatory process? Fertil Steril. 2012;97(1):7\u201312.","journal-title":"Fertil Steril"},{"issue":"7","key":"1647_CR24","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, Smolarczyk R, Meczekalski B. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3789.","journal-title":"Int J Mol Sci"},{"key":"1647_CR25","doi-asserted-by":"crossref","unstructured":"Zhang T, Tian F, Huo R, Tang A, Zeng Y, Duan YG. Detection of dendritic cells and related cytokines in follicular fluid of patients with polycystic ovary syndrome. Am J Reprod Immunol. 2017;78(3):12717.","DOI":"10.1111\/aji.12717"},{"key":"1647_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.685724","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu H, Li Z, Fan H, Yan X, Liu X, Xuan J, Feng D, Wei X. The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment. Front Immunol. 2021;12: 685724.","journal-title":"Front Immunol"},{"issue":"4","key":"1647_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","volume":"77","author":"F Gonzalez","year":"2012","unstructured":"Gonzalez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300\u20135.","journal-title":"Steroids"},{"key":"1647_CR28","doi-asserted-by":"crossref","unstructured":"Birney E. Mendelian Randomization. Cold Spring Harb Perspect Med. 2022;12(4):1\u201349.","DOI":"10.1101\/cshperspect.a040501"},{"issue":"5","key":"1647_CR29","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/ndt\/gfq098","volume":"25","author":"M Verduijn","year":"2010","unstructured":"Verduijn M, Siegerink B, Jager KJ, Zoccali C, Dekker FW. Mendelian randomization: use of genetics to enable causal inference in observational studies. Nephrol Dial Transplant. 2010;25(5):1394\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1647_CR30","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, Gutteridge A, Erola P, Liu Y, Luo S, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52(10):1122\u201331.","journal-title":"Nat Genet"},{"issue":"9","key":"1647_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101174","volume":"4","author":"S Yuan","year":"2023","unstructured":"Yuan S, Xu F, Li X, Chen J, Zheng J, Mantzoros CS, Larsson SC. Plasma proteins and onset of type 2 diabetes and diabetic complications: proteome-wide Mendelian randomization and colocalization analyses. Cell Rep Med. 2023;4(9): 101174.","journal-title":"Cell Rep Med"},{"issue":"12","key":"1647_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"Day F, Karaderi T, Jones MR, Meun C, He C, Drong A, Kraft P, Lin N, Huang H, Broer L, et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2018;14(12): e1007813.","journal-title":"PLoS Genet"},{"issue":"4","key":"1647_CR33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"key":"1647_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:7.","journal-title":"Elife"},{"issue":"5","key":"1647_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, Plagnol V. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5): e1004383.","journal-title":"PLoS Genet"},{"issue":"1","key":"1647_CR36","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Zeng J, Zhang F, Zhu Z, Qi T, Zheng Z, Lloyd-Jones LR, Marioni RE, Martin NG, Montgomery GW, et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat Commun. 2018;9(1):918.","journal-title":"Nat Commun"},{"key":"1647_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"1647_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003444","volume":"9","author":"RC Ferreira","year":"2013","unstructured":"Ferreira RC, Freitag DF, Cutler AJ, Howson JM, Rainbow DB, Smyth DJ, Kaptoge S, Clarke P, Boreham C, Coulson RM, et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet. 2013;9(4): e1003444.","journal-title":"PLoS Genet"},{"issue":"1","key":"1647_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.119143","volume":"1869","author":"T Schumertl","year":"2022","unstructured":"Schumertl T, Lokau J, Rose-John S, Garbers C. Function and proteolytic generation of the soluble interleukin-6 receptor in health and disease. Biochim Biophys Acta Mol Cell Res. 2022;1869(1): 119143.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"3","key":"1647_CR40","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","volume":"273","author":"T Imai","year":"1998","unstructured":"Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, Yoshie O, Gray PW. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem. 1998;273(3):1764\u20138.","journal-title":"J Biol Chem"},{"issue":"1","key":"1647_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jmii.2016.04.005","volume":"51","author":"YC Lin","year":"2018","unstructured":"Lin YC, Huang MY, Lee MS, Hsieh CC, Kuo HF, Kuo CH, Hung CH. Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages. J Microbiol Immunol Infect. 2018;51(1):18\u201326.","journal-title":"J Microbiol Immunol Infect"},{"key":"1647_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fendo.2013.00093","volume":"4","author":"S Tateya","year":"2013","unstructured":"Tateya S, Kim F, Tamori Y. Recent advances in obesity-induced inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;4:93.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1647_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fimmu.2020.00084","volume":"11","author":"SS Ferreira","year":"2020","unstructured":"Ferreira SS, Oliveira MA, Tsujita M, Nunes FPB, Casagrande FB, Gomes E, Russo M, Tavares de Lima W, Martins JO. Insulin modulates the immune cell phenotype in pulmonary allergic inflammation and increases pulmonary resistance in diabetic mice. Front Immunol. 2020;11:84.","journal-title":"Front Immunol"},{"issue":"1","key":"1647_CR44","doi-asserted-by":"publisher","first-page":"2115655","DOI":"10.1080\/2162402X.2022.2115655","volume":"11","author":"I Lecoq","year":"2022","unstructured":"Lecoq I, Kopp KL, Chapellier M, Mantas P, Martinenaite E, Perez-Penco M, Ronn Olsen L, Zocca MB, Wakatsuki Pedersen A, Andersen MH. CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment. Oncoimmunology. 2022;11(1):2115655.","journal-title":"Oncoimmunology"},{"issue":"3","key":"1647_CR45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/cen.13077","volume":"85","author":"K Luotola","year":"2016","unstructured":"Luotola K, Piltonen TT, Puurunen J, Tapanainen JS. IL-1 receptor antagonist levels are associated with glucose tolerance in polycystic ovary syndrome. Clin Endocrinol (Oxf). 2016;85(3):430\u20135.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7911","key":"1647_CR46","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-022-04718-w","volume":"605","author":"F Mair","year":"2022","unstructured":"Mair F, Erickson JR, Frutoso M, Konecny AJ, Greene E, Voillet V, Maurice NJ, Rongvaux A, Dixon D, Barber B, et al. Extricating human tumour immune alterations from tissue inflammation. Nature. 2022;605(7911):728\u201335.","journal-title":"Nature"},{"issue":"23","key":"1647_CR47","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.3390\/nu15234919","volume":"15","author":"F Chamorro","year":"2023","unstructured":"Chamorro F, Otero P, Carpena M, Fraga-Corral M, Echave J, Seyyedi-Mansour S, Cassani L, Prieto MA. Health benefits of oily fish: illustrated with blue shark (Prionace glauca), shortfin Mako shark (Isurus oxyrinchus), and swordfish (Xiphias gladius). Nutrients. 2023;15(23):4919.","journal-title":"Nutrients"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01647-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:09:12Z","timestamp":1743811752000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01647-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1647"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01647-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}